Brief: Quantum Genomics Presents Its 3-Year Strategic Plan

Quantum Genomics SA

19/04/2018 17:24

April 19 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA :
    * PRESENTS ITS 3-YEAR STRATEGIC PLAN.
    * ARTERIAL HYPERTENSION: COMPLETION OF NEW-HOPE STUDY
BROUGHT
FORWARD TO DECEMBER 2018
    * HEART FAILURE: EARLY LAUNCH OF A PHASE IIB STUDY IN 4(TH)
QUARTER 2018, ON BASIS OF GOOD PRODUCT SAFETY IN HEART FAILURE
PATIENTS
    * TO SIGN A STRATEGIC PARTNERSHIP OR LICENSE AGREEMENT WITH
A
PHARMACEUTICAL GROUP WITHIN 24 MONTHS
    * JEAN-PHILIPPE MILON NOW ASSUMES POSITION OF CEO

Source text for Eikon:  ID:nACT52836 
Further company coverage:  ALQGC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))